HOME >> MEDICINE >> NEWS
OTC statins: A bad decision for public health

This week's editorial raises concerns over the recent decision by the UK government to make the cholesterol-lowering drug simvastatin available over the counter (OTC) from July this year for people at moderate risk of cardiovascular disease.

The editorial comments: 'There are no trials of OTC statins for primary prevention of heart disease. There are no data on compliance with OTC statins, which for products that need to be taken daily longterm is a concern. Will those who buy simvastatin also stop smoking, lose weight, and do more exercise, or will they substitute drug use for lifestyle modification? Will pharmacists have the time to determine the individual's risk of coronary heart disease before selling the drug and also to give lifestyle advice? All these are unknowns, which is unfortunate for the UK public, who will be the guineapigs in this large-scale OTC experiment. Americans have escaped this role, with two applications for OTC statins (pravastatin 10 mg and lovastatin 10 mg) being rejected in 2000 because of insufficient evidence that either drug could be used safely and effectively in an OTC setting'.

Financial reasons are suggested as the driver behind the decision: 'In the absence of evidence of the overall mortality benefits of OTC simvastatin, it is difficult to avoid concluding that the motive behind the Government's decision is saving money. Statins are currently prescribed to about 1.8 million people in the UK, costing the NHS 700 million a year. With the NHS bill for statins predicted to be more than 2 billion a year by 2010, transferring costs to patients might seem timely. But privatising the prevention of heart disease will increase inequalities, with many unable to afford the likely 10-15 per month longterm. For the manufacturer, of course, the motive is clear. With simvastatin now off patent, creation of a new market (perhaps 8 million more people in the UK) will please shareholders'.

The editorial concludes: 'What i
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
20-May-2004


Page: 1 2

Related medicine news :

1. Teaching a less obvious medical skill -- Ethical decision-making
2. Balancing care decisions for gravely ill patients
3. How the stories of ordinary people could give them more say over planning decisions
4. Web-based tool to help clinicians make schizophrenia treatment decisions
5. Fair decisions more important when hospitals face crisis like SARS
6. Testosterone patch will test FDAs decision making
7. Aiding decision making for Baby Charlotte and Baby Luke
8. Scientists detect two decision-making pathways in human brain
9. Concerns about fertility affect treatment decisions in one-third of young breast cancer patients
10. Women pleased with preventative mastectomy decision
11. Exercise sharpens focus, decision-making among aging adults

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: OTC statins bad decision for public health

(Date:3/3/2015)... (PRWEB) March 03, 2015 eMedEvents, ... and continuing medical education (CME) credit information, has ... for doctors was initially launched in the United ... of its kind in the field of healthcare ... launch of this Denver, Colorado-based start-up company was ...
(Date:3/3/2015)... March 03, 2015 Venato, a ... announced that their flagship software solution now provides ... to be uploaded to the National Healthcare Safety ... Medicaid Services (CMS) require that hospitals submit healthcare ... no later than May 15 for each influenza ...
(Date:3/3/2015)... 03, 2015 Volpara Solutions, leaders in ... John D. Pavlidis has joined their Board of Directors. ... and executive management experience in the medical industry, including ... small organizations. , “John’s broad management experience in breast ... will be a tremendous asset to the sales, product ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 A recent ... confirms what water advocate and radio host Sharon Kleyne ... – lack of sufficient water in the body – ... as 90 percent of the US population. Kleyne further ... a factor in nearly all disease, including aging and ...
(Date:3/3/2015)... TX (PRWEB) March 03, 2015 ... Schumaker, RN, BSN, MBA, CEN, CPHQ, FABC as the ... to clinically-focused innovation for unscheduled, episodic care. ... care, making episodic care settings including urgent care and ... segments in healthcare,” said Roger Davis, T-System’s chief executive ...
Breaking Medicine News(10 mins):Health News:eMedEvents Launches Online Medical Conference, Speaker and CME Platform in India 2Health News:Venato Incorporates Automated NHSN Reporting Tool to Their Software Solution 2Health News:Volpara Solutions Adds Medical Imaging Veteran John Pavlidis to Board of Directors 2Health News:Volpara Solutions Adds Medical Imaging Veteran John Pavlidis to Board of Directors 3Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 2Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 3Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 3
(Date:3/3/2015)... 3, 2015   Mary,s Medicinals today announced ... for the legal-cannabis community with the latest nutritional science ... supplement line enriched with Cannabidiol (CBD) and other ... looking for accurately dosed, cleanly delivered CBD treatments. Due ... cannabis products out of Colorado . ...
(Date:3/3/2015)... , March 3, 2015 Men with ... the prostate is enlarged but not cancerous, have ... invasive and has fewer complications than other minimally ... prostate and surgical options, according to research presented ...  (SIR,s) Annual Scientific Meeting . Using an ...
(Date:3/3/2015)... 3, 2015 Although lung cancer is the ... are only 18 drugs in the market for its ... are nearing their patent expiry in 2015 and 2017 ... vast potential that drug manufacturers are vying to tap ... cell lung cancer (SCLC) and non-small cell lung cancer ...
Breaking Medicine Technology:Mary's Medicinals Unveils Mary's Nutritionals, a Nationally Available Line of Wellness Supplements Enriched with CBD and Plant Nutrients 2Mary's Medicinals Unveils Mary's Nutritionals, a Nationally Available Line of Wellness Supplements Enriched with CBD and Plant Nutrients 3Interventional radiology offers new treatment for enlarged prostates 2Interventional radiology offers new treatment for enlarged prostates 3Interventional radiology offers new treatment for enlarged prostates 4Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3
Cached News: